Literature DB >> 32487907

Coding in the World of COVID-19: Non-Face-to-Face Evaluation and Management Care.

Bruce H Cohen, Neil A Busis, Luana Ciccarelli.   

Abstract

Almost all medical care in the United States is delivered with the provider and patient in immediate proximity; this model is referred to as face-to-face care. Medical services can be apportioned as procedural care (eg, surgery, radiology, or laboratory testing and others) or cognitive care, also known as Evaluation and Management (E/M) services, in which the provider formulates an assessment and plan after obtaining information from the patient's history, examination, and diagnostic tests.Providing a medical opinion and plan using the telephone as the technology that links the provider and the patient is an example of a non-face-to-face E/M service. Common Procedural Terminology (CPT) codes and the details for how to provide telephone services have been available for decades but have not been reimbursed and therefore were rarely used. In recent years, as new technologies have evolved, there has been slow and steady acceptance that non-face-to-face E/M care can be an adjunct to or replacement for some face-to-face E/M services. These technologies and the descriptors for associated CPT and Healthcare Common Procedure Coding System (HCPCS) codes were introduced over the past few years and have become known by the generic term telehealth. They have been slowly incorporated into medical practice. Most of these services were introduced in the consumer retail market, in which the cost was borne directly by the patient, or as private contract services, in which the cost was borne by the consulting hospital, such as with telestroke services. In both the consumer retail model and private contract model, the care delivered usually did not involve CPT or HCPCS coding. The adoption of telehealth has been slow, in part because of the initial costs and several regulatory constraints, as well as the reluctance of patients, providers, and the insurance industry to change the concept that medical care could only be delivered when the patient and their provider were in physical proximity.After the COVID-19 pandemic reached the United States, the US Department of Health & Human Services issued a public health emergency and declared a Section 1135 Waiver that lifted many of the administrative constraints. With the need for near-absolute social distancing, this perfect storm has resulted in the immediate adoption of telemedicine, at least for the duration of the pandemic, for cognitive care to be delivered using communication technologies that are already in place. This article discusses the most common forms of non-face-to-face E/M care and the proper coding elements necessary to provide these services.

Entities:  

Mesh:

Year:  2020        PMID: 32487907     DOI: 10.1212/CON.0000000000000874

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  10 in total

Review 1.  Impact of Covid-19 on research and training in Parkinson's disease.

Authors:  Yi-Min Wan; Daniel J van Wamelen; Yue Hui Lau; Silvia Rota; Eng-King Tan
Journal:  Int Rev Neurobiol       Date:  2022-05-04       Impact factor: 4.280

2.  No lockdown for neurological diseases during COVID19 pandemic infection.

Authors:  Valeria Caso; Antonio Federico
Journal:  Neurol Sci       Date:  2020-05       Impact factor: 3.307

3.  Neuro-ophthalmology in the Era of COVID-19: Future Implications of a Public Health Crisis.

Authors:  Scott N Grossman; Rachel Calix; Sharon Tow; Jeffrey G Odel; Linus D Sun; Laura J Balcer; Steven L Galetta; Janet C Rucker
Journal:  Ophthalmology       Date:  2020-05-07       Impact factor: 12.079

4.  Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase.

Authors:  Eleonora Mauri; Elena Abati; Olimpia Musumeci; Carmelo Rodolico; Maria Grazia D'Angelo; Massimiliano Mirabella; Matteo Lucchini; Luca Bello; Elena Pegoraro; Lorenzo Maggi; Letizia Manneschi; Chiara Gemelli; Marina Grandis; Angela Zuppa; Sara Massucco; Luana Benedetti; Claudia Caponnetto; Angelo Schenone; Alessandro Prelle; Stefano C Previtali; Marina Scarlato; Adele D'Amico; Enrico Bertini; Elena M Pennisi; Laura De Giglio; Marika Pane; Eugenio Mercuri; Tiziana Mongini; Federica Ricci; Angela Berardinelli; Guja Astrea; Sara Lenzi; Roberta Battini; Giulia Ricci; Francesca Torri; Gabriele Siciliano; Filippo M Santorelli; Alessandra Ariatti; Massimiliano Filosto; Luigia Passamano; Luisa Politano; Marianna Scutifero; Paola Tonin; Barbara Fossati; Chiara Panicucci; Claudio Bruno; Sabrina Ravaglia; Mauro Monforte; Giorgio Tasca; Enzo Ricci; Antonio Petrucci; Lucio Santoro; Lucia Ruggiero; Andrea Barp; Emilio Albamonte; Valeria Sansone; Delia Gagliardi; Gianluca Costamagna; Alessandra Govoni; Francesca Magri; Roberta Brusa; Daniele Velardo; Megi Meneri; Monica Sciacco; Stefania Corti; Nereo Bresolin; Isabella Moroni; Sonia Messina; Antonio Di Muzio; Vincenzo Nigro; Rocco Liguori; Giovanni Antonini; Antonio Toscano; Carlo Minetti; Giacomo Pietro Comi
Journal:  Acta Myol       Date:  2020-06-01

Review 5.  Pediatric Endocrinology in the Time of COVID-19: Considerations for the Rapid Implementation of Telemedicine and Management of Pediatric Endocrine Conditions.

Authors:  Molly O Regelmann; Rushika Conroy; Evgenia Gourgari; Anshu Gupta; Ines Guttmann-Bauman; Ryan Heksch; Manmohan K Kamboj; Sowmya Krishnan; Amit Lahoti; Kristal Matlock
Journal:  Horm Res Paediatr       Date:  2021-01-22       Impact factor: 2.852

6.  Delivering multidisciplinary neuromuscular care for children via telehealth.

Authors:  Kate Carroll; Justine Adams; Katy de Valle; Robin Forbes; Rachel A Kennedy; Andrew J Kornberg; Moya Vandeleur; Daniella Villano; Ian R Woodcock; Eppie M Yiu; Monique M Ryan; Zoe Davidson
Journal:  Muscle Nerve       Date:  2022-04-29       Impact factor: 3.852

Review 7.  The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic.

Authors:  Aravindhan Veerapandiyan; Kathryn R Wagner; Susan Apkon; Craig M McDonald; Katherine D Mathews; Julie A Parsons; Brenda L Wong; Katy Eichinger; Perry B Shieh; Russell J Butterfield; Vamshi K Rao; Edward C Smith; Crystal M Proud; Anne M Connolly; Emma Ciafaloni
Journal:  Muscle Nerve       Date:  2020-05-05       Impact factor: 3.852

Review 8.  Spinal muscular atrophy care in the COVID-19 pandemic era.

Authors:  Aravindhan Veerapandiyan; Anne M Connolly; Richard S Finkel; Kapil Arya; Katherine D Mathews; Edward C Smith; Diana Castro; Russell J Butterfield; Julie A Parsons; Laurent Servais; Nancy Kuntz; Vamshi K Rao; John F Brandsema; Eugenio Mercuri; Emma Ciafaloni
Journal:  Muscle Nerve       Date:  2020-05-03       Impact factor: 3.852

9.  Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic.

Authors:  Proleta Datta; Wattana Barrett; Monica Bentzinger; Tracy Jasinski; Lakshman Arcot Jayagopal; Alexa Mahoney; Crystal Pearon; Arun Swaminathan; Aditya Vuppala; Kaeli K Samson; Hongmei Wang; Olga Taraschenko
Journal:  Epilepsy Behav       Date:  2021-02-02       Impact factor: 2.937

10.  Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus.

Authors:  Vahid Shaygannejad; Alireza Afshari-Safavi; Boshra Hatef
Journal:  Neurol Sci       Date:  2020-11-20       Impact factor: 3.830

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.